These data confirm that in primary HER2-positive breast cancer, STAT3 participates in oncogenesis through the up-regulation of genes encoding cell-cycle regulators and that PTEN loss may be associated with STAT3 activation. This evidence concerns the gene STAT3 and breast cancer.